Average Price Target: $129.40
▲ +39.62% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Inari Medical in the last 3 months. The average price target is $129.40, with a high forecast of $135.00 and a low forecast of $125.00. The average price target represents a 39.62% upside from the last price of $92.68.
The current consensus among 5 polled investment analysts is to buy stock in Inari Medical.
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.